- Home
- ACTU vs MSD Comparison
ACTU vs MSD Comparison
Compare ACTU & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- MSD
- Stock Information
- Founded
- ACTU 2015
- MSD 1993
- Country
- ACTU United States
- MSD United States
- Employees
- ACTU N/A
- MSD N/A
- Industry
- ACTU
- MSD Trusts Except Educational Religious and Charitable
- Sector
- ACTU
- MSD Finance
- Exchange
- ACTU NYSE
- MSD Nasdaq
- Market Cap
- ACTU 135.0M
- MSD 144.6M
- IPO Year
- ACTU 2024
- MSD N/A
- Fundamental
- Price
- ACTU $11.90
- MSD $7.70
- Analyst Decision
- ACTU Strong Buy
- MSD
- Analyst Count
- ACTU 1
- MSD 0
- Target Price
- ACTU $20.00
- MSD N/A
- AVG Volume (30 Days)
- ACTU 68.4K
- MSD 70.2K
- Earning Date
- ACTU 05-15-2025
- MSD 01-01-0001
- Dividend Yield
- ACTU N/A
- MSD 11.26%
- EPS Growth
- ACTU N/A
- MSD N/A
- EPS
- ACTU N/A
- MSD N/A
- Revenue
- ACTU N/A
- MSD N/A
- Revenue This Year
- ACTU N/A
- MSD N/A
- Revenue Next Year
- ACTU N/A
- MSD N/A
- P/E Ratio
- ACTU N/A
- MSD N/A
- Revenue Growth
- ACTU N/A
- MSD N/A
- 52 Week Low
- ACTU $5.51
- MSD $6.11
- 52 Week High
- ACTU $11.99
- MSD $7.46
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- MSD 56.46
- Support Level
- ACTU N/A
- MSD $7.63
- Resistance Level
- ACTU N/A
- MSD $7.73
- Average True Range (ATR)
- ACTU 0.00
- MSD 0.07
- MACD
- ACTU 0.00
- MSD 0.02
- Stochastic Oscillator
- ACTU 0.00
- MSD 85.71
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About MSD Morgan Stanley Emerging Markets Debt Fund Inc.
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.